|1.||Raatikainen, M J: 1 article (11/2000)|
|2.||Dennis, D M: 1 article (11/2000)|
|3.||Gonzalez, M D: 1 article (11/2000)|
|4.||Druzgala, P: 1 article (11/2000)|
|5.||Milner, P: 1 article (11/2000)|
|6.||Morey, T E: 1 article (11/2000)|
06/01/1996 - "The lack of reverse frequency-dependent effects on ventricular repolarization and refractoriness suggests that ATI-2001 may be more efficacious than d-sotalol or other pure class III drugs in treating ventricular tachycardias and less likely to become proarrhythmic at normal or slow heart rates."
11/01/2000 - "Given these data, ATI-2001 should not only be useful for terminating ongoing and preventing reoccurrence of atrial tachyarrhythmias but also to treat supraventricular tachycardias involving the AV node and to control ventricular rate during atrial tachyarrhythmias. "
11/01/2000 - "Whether the observed differences in the pharmacokinetic properties render ATI-2001 superior to amiodarone in acute tachyarrhythmia management and less likely to accumulate into tissues during chronic therapy remains to be established."
11/01/2000 - "We recently demonstrated that the short-acting analog of amiodarone, ATI-2001, caused favorable effects in guinea pig ventricular myocardium on electrophysiological substrates underlying tachyarrhythmia initiation, perpetuation, and termination. "
|1.||Sotalol (Sotalol Hydrochloride)